|
|
inflammatory response
|
GO:0006954 |
244 |
0.417
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.335
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.306
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.206
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.161
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.148
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.146
|
|
|
|
vasodilation
|
GO:0042311 |
28 |
0.129
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.117
|
|
|
|
regulation of systemic arterial blood pressure
|
GO:0003073 |
61 |
0.108
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.104
|
|
|
|
arachidonic acid metabolite production involved in inflammatory response
|
GO:0002538 |
2 |
0.096
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.091
|
|
|
|
regulation of renin secretion into blood stream
|
GO:1900133 |
4 |
0.087
|
|
|
|
regulation of systemic arterial blood pressure mediated by a chemical signal
|
GO:0003044 |
33 |
0.086
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.079
|
|
|
|
vascular process in circulatory system
|
GO:0003018 |
62 |
0.078
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.077
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.077
|
|
|
|
positive regulation of the force of heart contraction by chemical signal
|
GO:0003099 |
3 |
0.073
|
|
|
|
negative regulation of cell motility
|
GO:2000146 |
61 |
0.070
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.069
|
|
|
|
fatty acid derivative biosynthetic process
|
GO:1901570 |
15 |
0.069
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.068
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.068
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.068
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.068
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.067
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.066
|
|
|
|
leukotriene production involved in inflammatory response
|
GO:0002540 |
2 |
0.066
|
|
|
|
operant conditioning
|
GO:0035106 |
2 |
0.065
|
|
|
|
fatty acid derivative metabolic process
|
GO:1901568 |
33 |
0.064
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.064
|
|
|
|
g protein coupled receptor internalization
|
GO:0002031 |
3 |
0.064
|
|
|
|
cell communication by chemical coupling
|
GO:0010643 |
2 |
0.063
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.063
|
|
|
|
unsaturated fatty acid metabolic process
|
GO:0033559 |
31 |
0.063
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.062
|
|
|
|
regulation of satellite cell activation involved in skeletal muscle regeneration
|
GO:0014717 |
3 |
0.062
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.060
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.060
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.056
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.056
|
|
|
|
regulation of membrane depolarization during action potential
|
GO:0098902 |
1 |
0.055
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.054
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.053
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.053
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.053
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.052
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.052
|
|
|
|
gastrin induced gastric acid secretion
|
GO:0001698 |
1 |
0.052
|
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.052
|
|
|
|
av node cell to bundle of his cell communication
|
GO:0086067 |
2 |
0.051
|
|
|
|
female sex differentiation
|
GO:0046660 |
84 |
0.049
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.049
|
|
|
|
vasodilation by norepinephrine epinephrine involved in regulation of systemic arterial blood pressure
|
GO:0002025 |
3 |
0.048
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.048
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.048
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.048
|
|
|
|
fatty acid biosynthetic process
|
GO:0006633 |
41 |
0.048
|
|
|
|
milk ejection
|
GO:0060156 |
1 |
0.048
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.047
|
|
|
|
regulation of tube size
|
GO:0035150 |
57 |
0.047
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.047
|
|
|
|
icosanoid metabolic process
|
GO:0006690 |
33 |
0.047
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.047
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.046
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.045
|
|
|
|
protein citrullination
|
GO:0018101 |
2 |
0.045
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.045
|
|
|
|
regulation of blood vessel size
|
GO:0050880 |
56 |
0.045
|
|
|
|
regulation of systemic arterial blood pressure by hormone
|
GO:0001990 |
25 |
0.044
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.044
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.043
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.043
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.043
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.042
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.042
|
|
|
|
histamine induced gastric acid secretion
|
GO:0001697 |
1 |
0.042
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.042
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.042
|
|
|
|
icosanoid biosynthetic process
|
GO:0046456 |
15 |
0.041
|
|
|
|
positive regulation of cytosolic calcium ion concentration involved in phospholipase c activating g protein coupled signaling pathway
|
GO:0051482 |
4 |
0.041
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.041
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.040
|
|
|
|
ventricular cardiac muscle cell action potential
|
GO:0086005 |
4 |
0.040
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.040
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.039
|
|
|
|
cellular response to temperature stimulus
|
GO:0071502 |
2 |
0.039
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.039
|
|
|
|
protein kinase c activating g protein coupled receptor signaling pathway
|
GO:0007205 |
4 |
0.039
|
|
|
|
regulation of membrane depolarization during cardiac muscle cell action potential
|
GO:1900825 |
1 |
0.038
|
|
|
|
positive regulation of heart rate by epinephrine norepinephrine
|
GO:0001996 |
4 |
0.038
|
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
119 |
0.038
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.038
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.037
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
59 |
0.037
|
|
|
|
foramen ovale closure
|
GO:0035922 |
1 |
0.037
|
|
|
|
smooth muscle contraction
|
GO:0006939 |
44 |
0.037
|
|
|
|
unsaturated fatty acid biosynthetic process
|
GO:0006636 |
15 |
0.037
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.037
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.037
|
|
|
|
positive regulation of glycolytic process
|
GO:0045821 |
4 |
0.036
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.036
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.036
|
|
|
|
regulation of muscle contraction
|
GO:0006937 |
49 |
0.036
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.036
|
|
|
|
satellite cell activation involved in skeletal muscle regeneration
|
GO:0014901 |
3 |
0.036
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
71 |
0.035
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.035
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.035
|
|
|
|
hair cycle
|
GO:0042633 |
90 |
0.035
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.035
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.035
|
|
|
|
sa node cell action potential
|
GO:0086015 |
4 |
0.035
|
|
|
|
phospholipase c activating serotonin receptor signaling pathway
|
GO:0007208 |
1 |
0.035
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.035
|
|
|
|
positive regulation of response to wounding
|
GO:1903036 |
66 |
0.035
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.034
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.034
|
|
|
|
regulation of action potential
|
GO:0098900 |
4 |
0.034
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.034
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.034
|
|
|
|
renal system process
|
GO:0003014 |
48 |
0.034
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
79 |
0.034
|
|
|
|
regulation of ventricular cardiac muscle cell membrane depolarization
|
GO:0060373 |
2 |
0.033
|
|
|
|
monocarboxylic acid biosynthetic process
|
GO:0072330 |
61 |
0.033
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.033
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.033
|
|
|
|
septum primum development
|
GO:0003284 |
4 |
0.033
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.033
|
|
|
|
biomineral tissue development
|
GO:0031214 |
64 |
0.033
|
|
|
|
positive regulation of blood pressure
|
GO:0045777 |
21 |
0.033
|
|
|
|
atrial ventricular junction remodeling
|
GO:0003294 |
2 |
0.032
|
|
|
|
regulation of tissue remodeling
|
GO:0034103 |
38 |
0.032
|
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
86 |
0.032
|
|
|
|
adenylate cyclase modulating g protein coupled receptor signaling pathway
|
GO:0007188 |
54 |
0.032
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.032
|
|
|
|
bone remodeling
|
GO:0046849 |
53 |
0.031
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.031
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.031
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.031
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.031
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.031
|
|
|
|
renal system process involved in regulation of systemic arterial blood pressure
|
GO:0003071 |
15 |
0.030
|
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
86 |
0.030
|
|
|
|
membrane lipid biosynthetic process
|
GO:0046467 |
32 |
0.030
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.030
|
|
|
|
planar cell polarity pathway involved in cardiac right atrium morphogenesis
|
GO:0061349 |
2 |
0.030
|
|
|
|
renal system process involved in regulation of blood volume
|
GO:0001977 |
4 |
0.030
|
|
|
|
negative regulation of muscle contraction
|
GO:0045932 |
12 |
0.030
|
|
|
|
membrane depolarization
|
GO:0051899 |
64 |
0.030
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.030
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.029
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.029
|
|
|
|
hair follicle development
|
GO:0001942 |
85 |
0.029
|
|
|
|
positive regulation of stem cell proliferation
|
GO:2000648 |
59 |
0.029
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.029
|
|
|
|
water homeostasis
|
GO:0030104 |
27 |
0.029
|
|
|
|
epithelial cell migration
|
GO:0010631 |
63 |
0.029
|
|
|
|
corticotropin releasing hormone secretion
|
GO:0043396 |
2 |
0.029
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.028
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.028
|
|
|
|
positive regulation of the force of heart contraction by epinephrine norepinephrine
|
GO:0001997 |
3 |
0.028
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.028
|
|
|
|
sodium ion transport
|
GO:0006814 |
73 |
0.028
|
|
|
|
molting cycle
|
GO:0042303 |
90 |
0.028
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.028
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.028
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.028
|
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.028
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.028
|
|
|
|
regulation of cell size
|
GO:0008361 |
72 |
0.027
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.027
|
|
|
|
sa node cell to atrial cardiac muscle cell signalling
|
GO:0086018 |
4 |
0.027
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.026
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.026
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.026
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.026
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.026
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.026
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.026
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.025
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.025
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.025
|
|
|
|
regulation of extent of cell growth
|
GO:0061387 |
52 |
0.025
|
|
|
|
renal response to blood flow involved in circulatory renin angiotensin regulation of systemic arterial blood pressure
|
GO:0001999 |
6 |
0.025
|
|
|
|
negative regulation of defense response
|
GO:0031348 |
77 |
0.025
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.025
|
|
|
|
response to monosaccharide
|
GO:0034284 |
67 |
0.025
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.025
|
|
|
|
positive regulation of cell growth
|
GO:0030307 |
33 |
0.025
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.025
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.025
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.025
|
|
|
|
habituation
|
GO:0046959 |
3 |
0.025
|
|
|
|
positive regulation of protein secretion
|
GO:0050714 |
52 |
0.024
|
|
|
|
positive regulation of interleukin 8 secretion
|
GO:2000484 |
1 |
0.024
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.024
|
|
|
|
female gonad development
|
GO:0008585 |
71 |
0.024
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.024
|
|
|
|
acid secretion
|
GO:0046717 |
33 |
0.024
|
|
|
|
hemostasis
|
GO:0007599 |
78 |
0.024
|
|
|
|
response to steroid hormone
|
GO:0048545 |
56 |
0.024
|
|
|
|
interleukin 8 production
|
GO:0032637 |
4 |
0.024
|
|
|
|
regeneration
|
GO:0031099 |
38 |
0.024
|
|
|
|
myotube cell development
|
GO:0014904 |
60 |
0.024
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.024
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.024
|
|
|
|
myoblast differentiation involved in skeletal muscle regeneration
|
GO:0014835 |
3 |
0.024
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.024
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.024
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.023
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.023
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.023
|
|
|
|
interleukin 8 secretion
|
GO:0072606 |
3 |
0.023
|
|
|
|
activation of adenylate cyclase activity
|
GO:0007190 |
4 |
0.023
|
|
|
|
striated muscle contraction
|
GO:0006941 |
45 |
0.023
|
|
|
|
intermediate filament cytoskeleton organization
|
GO:0045104 |
26 |
0.023
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.023
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.023
|
|
|
|
cytokine secretion
|
GO:0050663 |
72 |
0.023
|
|
|
|
blood coagulation
|
GO:0007596 |
76 |
0.023
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.023
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.023
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.023
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.023
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.022
|
|
|
|
tertiary branching involved in mammary gland duct morphogenesis
|
GO:0060748 |
3 |
0.022
|
|
|
|
regulation of excitatory postsynaptic membrane potential
|
GO:0060079 |
41 |
0.022
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.022
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.022
|
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.022
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.022
|
|
|
|
regulation of endocytosis
|
GO:0030100 |
69 |
0.022
|
|
|
|
ribose phosphate biosynthetic process
|
GO:0046390 |
59 |
0.022
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.022
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.022
|
|
|
|
neuron neuron synaptic transmission
|
GO:0007270 |
69 |
0.022
|
|
|
|
mesonephric epithelium development
|
GO:0072163 |
94 |
0.022
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.022
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.022
|
|
|
|
negative regulation of systemic arterial blood pressure
|
GO:0003085 |
15 |
0.022
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.022
|
|
|
|
negative regulation of endopeptidase activity
|
GO:0010951 |
44 |
0.022
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.021
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.021
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.021
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.021
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.021
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.021
|
|
|
|
negative regulation of response to wounding
|
GO:1903035 |
77 |
0.021
|
|
|
|
pyruvate metabolic process
|
GO:0006090 |
28 |
0.021
|
|
|
|
positive regulation of ossification
|
GO:0045778 |
47 |
0.021
|
|
|
|
bone mineralization
|
GO:0030282 |
54 |
0.021
|
|
|
|
cell communication by electrical coupling involved in cardiac conduction
|
GO:0086064 |
2 |
0.021
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.021
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.021
|
|
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
0 |
0.021
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.021
|
|
|
|
myoblast differentiation
|
GO:0045445 |
52 |
0.021
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.021
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.021
|
|
|
|
regulation of cardiac muscle cell action potential
|
GO:0098901 |
1 |
0.020
|
|
|
|
intermediate filament based process
|
GO:0045103 |
27 |
0.020
|
|
|
|
negative regulation of androgen biosynthetic process
|
GO:2000180 |
1 |
0.020
|
|
|
|
mesonephros development
|
GO:0001823 |
97 |
0.020
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.020
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.020
|
|
|
|
lipoxin a4 biosynthetic process
|
GO:2001303 |
1 |
0.020
|
|
|
|
regulation of systemic arterial blood pressure by circulatory renin angiotensin
|
GO:0001991 |
13 |
0.020
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.020
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.020
|
|
|
|
negative regulation of peptidase activity
|
GO:0010466 |
46 |
0.020
|
|
|
|
cellular response to starvation
|
GO:0009267 |
57 |
0.020
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.020
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.020
|
|
|
|
interleukin 1 production
|
GO:0032612 |
31 |
0.020
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.020
|
|
|
|
regulation of serotonin secretion
|
GO:0014062 |
3 |
0.020
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.020
|
|
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.020
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.020
|
|
|
|
androgen biosynthetic process
|
GO:0006702 |
4 |
0.020
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.020
|
|
|
|
negative regulation of blood pressure
|
GO:0045776 |
22 |
0.019
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.019
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.019
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.019
|
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.019
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.019
|
|
|
|
response to estrogen
|
GO:0043627 |
24 |
0.019
|
|
|
|
positive regulation of rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0045899 |
2 |
0.019
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.019
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.019
|
|
|
|
regulation of chemokine production
|
GO:0032642 |
30 |
0.019
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.019
|
|
|
|
lipoxygenase pathway
|
GO:0019372 |
5 |
0.019
|
|
|
|
regulation of biomineral tissue development
|
GO:0070167 |
33 |
0.019
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.019
|
|
|
|
regulation of protein secretion
|
GO:0050708 |
82 |
0.019
|
|
|
|
negative regulation of serotonin secretion
|
GO:0014063 |
2 |
0.019
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.019
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.019
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.019
|
|
|
|
testosterone biosynthetic process
|
GO:0061370 |
2 |
0.019
|
|
|
|
sensitization
|
GO:0046960 |
2 |
0.019
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.018
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.018
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.018
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
124 |
0.018
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.018
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.018
|
|
|
|
positive regulation of angiogenesis
|
GO:0045766 |
46 |
0.018
|
|
|
|
cyclic nucleotide metabolic process
|
GO:0009187 |
59 |
0.018
|
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.018
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.018
|
|
|
|
regulation of interleukin 8 production
|
GO:0032677 |
3 |
0.018
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.018
|
|
|
|
development of primary female sexual characteristics
|
GO:0046545 |
73 |
0.018
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.018
|
|
|
|
developmental cell growth
|
GO:0048588 |
84 |
0.018
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.018
|
|
|
|
epithelial cell morphogenesis
|
GO:0003382 |
41 |
0.018
|
|
|
|
diterpenoid metabolic process
|
GO:0016101 |
24 |
0.018
|
|
|
|
bone resorption
|
GO:0045453 |
38 |
0.018
|
|
|
|
alpha beta t cell differentiation
|
GO:0046632 |
69 |
0.018
|
|
|
|
ureteric bud development
|
GO:0001657 |
94 |
0.018
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.017
|
|
|
|
nucleotide biosynthetic process
|
GO:0009165 |
78 |
0.017
|
|
|
|
glycerolipid biosynthetic process
|
GO:0045017 |
50 |
0.017
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.017
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.017
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.017
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.017
|
|
|
|
regulation of metal ion transport
|
GO:0010959 |
106 |
0.017
|
|
|
|
g protein coupled receptor signaling pathway coupled to cyclic nucleotide second messenger
|
GO:0007187 |
55 |
0.017
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.017
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.017
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.017
|
|
|
|
mesangial cell differentiation
|
GO:0072007 |
4 |
0.017
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.017
|
|
|
|
regulation of interleukin 8 secretion
|
GO:2000482 |
2 |
0.017
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.017
|
|
|
|
sphingolipid biosynthetic process
|
GO:0030148 |
26 |
0.017
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.017
|
|
|
|
positive regulation of cytokine secretion
|
GO:0050715 |
41 |
0.017
|
|
|
|
regulation of leukocyte proliferation
|
GO:0070663 |
121 |
0.017
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.017
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
64 |
0.017
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.017
|
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.017
|
|
|
|
regulation of muscle system process
|
GO:0090257 |
80 |
0.017
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.017
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.016
|
|
|
|
regulation of renal sodium excretion
|
GO:0035813 |
3 |
0.016
|
|
|
|
regulation of nucleotide biosynthetic process
|
GO:0030808 |
34 |
0.016
|
|
|
|
purine containing compound biosynthetic process
|
GO:0072522 |
70 |
0.016
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.016
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.016
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.016
|
|
|
|
temperature homeostasis
|
GO:0001659 |
26 |
0.016
|
|
|
|
production of molecular mediator involved in inflammatory response
|
GO:0002532 |
21 |
0.016
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.016
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.016
|
|
|
|
regulation of sodium ion transport
|
GO:0002028 |
29 |
0.016
|
|
|
|
regulation of water loss via skin
|
GO:0033561 |
16 |
0.016
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.016
|
|
|
|
regulation of bone mineralization
|
GO:0030500 |
31 |
0.016
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.016
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.016
|
|
|
|
negative regulation of lipid metabolic process
|
GO:0045833 |
30 |
0.016
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.016
|
|
|
|
response to glucocorticoid
|
GO:0051384 |
20 |
0.016
|
|
|
|
peristalsis
|
GO:0030432 |
8 |
0.016
|
|
|
|
positive regulation of cell cell adhesion mediated by cadherin
|
GO:2000049 |
2 |
0.016
|
|
|
|
immune response regulating cell surface receptor signaling pathway
|
GO:0002768 |
80 |
0.016
|
|
|
|
paraxial mesodermal cell differentiation
|
GO:0048342 |
2 |
0.016
|
|
|
|
cellular response to biotic stimulus
|
GO:0071216 |
92 |
0.016
|
|
|
|
renal sodium excretion
|
GO:0035812 |
3 |
0.016
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.016
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.016
|
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
79 |
0.016
|
|
|
|
mesendoderm development
|
GO:0048382 |
3 |
0.016
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.015
|
|
|
|
regulation of interferon gamma production
|
GO:0032649 |
57 |
0.015
|
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.015
|
|
|
|
regulation of cell cell adhesion mediated by cadherin
|
GO:2000047 |
2 |
0.015
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.015
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.015
|
|
|
|
metanephric glomerular endothelium development
|
GO:0072264 |
1 |
0.015
|
|
|
|
pole plasm assembly
|
GO:0007315 |
2 |
0.015
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.015
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.015
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.015
|
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
81 |
0.015
|
|
|
|
positive regulation of inflammatory response
|
GO:0050729 |
47 |
0.015
|
|
|
|
intermediate filament organization
|
GO:0045109 |
15 |
0.015
|
|
|
|
actin mediated cell contraction
|
GO:0070252 |
15 |
0.015
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.015
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.015
|
|
|
|
transforming growth factor beta2 production
|
GO:0032906 |
2 |
0.015
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.015
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.015
|
|
|
|
negative regulation of testosterone biosynthetic process
|
GO:2000225 |
1 |
0.015
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.015
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.015
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.015
|
|
|
|
positive regulation of interleukin 8 production
|
GO:0032757 |
2 |
0.015
|
|
|
|
negative regulation of g protein coupled receptor protein signaling pathway
|
GO:0045744 |
12 |
0.015
|
|
|
|
regulation of axon extension
|
GO:0030516 |
43 |
0.015
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.015
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.015
|
|
|
|
negative regulation of hormone biosynthetic process
|
GO:0032353 |
4 |
0.015
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.014
|
|
|
|
response to drug
|
GO:0042493 |
75 |
0.014
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.014
|
|
|
|
hepatocyte apoptotic process
|
GO:0097284 |
11 |
0.014
|
|
|
|
feeding behavior
|
GO:0007631 |
62 |
0.014
|
|
|
|
multicellular organismal water homeostasis
|
GO:0050891 |
23 |
0.014
|
|
|
|
response to parathyroid hormone
|
GO:0071107 |
3 |
0.014
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.014
|
|
|
|
chondrocyte hypertrophy
|
GO:0003415 |
4 |
0.014
|
|
|
|
negative regulation of smooth muscle contraction
|
GO:0045986 |
10 |
0.014
|
|
|
|
tissue regeneration
|
GO:0042246 |
22 |
0.014
|
|
|
|
serotonin metabolic process
|
GO:0042428 |
8 |
0.014
|
|
|
|
fat soluble vitamin biosynthetic process
|
GO:0042362 |
4 |
0.014
|
|
|
|
skeletal muscle tissue regeneration
|
GO:0043403 |
20 |
0.014
|
|
|
|
protein localization to cell junction
|
GO:1902414 |
3 |
0.014
|
|
|
|
brown fat cell differentiation
|
GO:0050873 |
36 |
0.014
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.014
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.014
|
|
|
|
wnt signaling pathway involved in forebrain neuroblast division
|
GO:0021874 |
2 |
0.014
|
|
|
|
cell cell junction organization
|
GO:0045216 |
72 |
0.014
|
|
|
|
purinergic nucleotide receptor signaling pathway
|
GO:0035590 |
3 |
0.014
|
|
|
|
tissue migration
|
GO:0090130 |
68 |
0.014
|
|
|
|
stem cell fate specification
|
GO:0048866 |
3 |
0.014
|
|
|
|
regulation of wound healing
|
GO:0061041 |
40 |
0.014
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.014
|
|
|
|
regulation of ketone biosynthetic process
|
GO:0010566 |
2 |
0.014
|
|
|
|
acute inflammatory response
|
GO:0002526 |
41 |
0.014
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
68 |
0.014
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.014
|
|
|
|
cell junction maintenance
|
GO:0034331 |
4 |
0.014
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
85 |
0.014
|
|
|
|
protein import into nucleus
|
GO:0006606 |
95 |
0.014
|
|
|
|
regulation of glomerular filtration
|
GO:0003093 |
3 |
0.014
|
|
|
|
cofactor metabolic process
|
GO:0051186 |
80 |
0.014
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.014
|
|
|
|
dna templated transcriptional preinitiation complex assembly
|
GO:0070897 |
4 |
0.014
|
|
|
|
regulation of cyclic nucleotide metabolic process
|
GO:0030799 |
40 |
0.014
|
|
|
|
nephron epithelium morphogenesis
|
GO:0072088 |
68 |
0.014
|
|
|
|
wound healing involved in inflammatory response
|
GO:0002246 |
4 |
0.014
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.014
|
|
|
|
regulation of peptide secretion
|
GO:0002791 |
77 |
0.013
|
|
|
|
phospholipase c activating g protein coupled receptor signaling pathway
|
GO:0007200 |
26 |
0.013
|
|
|
|
renal vesicle induction
|
GO:0072034 |
3 |
0.013
|
|
|
|
coagulation
|
GO:0050817 |
78 |
0.013
|
|
|
|
regulation of smooth muscle contraction
|
GO:0006940 |
22 |
0.013
|
|
|
|
response to epidermal growth factor
|
GO:0070849 |
4 |
0.013
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.013
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.013
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.013
|
|
|
|
phasic smooth muscle contraction
|
GO:0014821 |
8 |
0.013
|
|
|
|
artery development
|
GO:0060840 |
53 |
0.013
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.013
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
65 |
0.013
|
|
|
|
glycerophospholipid biosynthetic process
|
GO:0046474 |
32 |
0.013
|
|
|
|
actin filament based movement
|
GO:0030048 |
23 |
0.013
|
|
|
|
establishment of skin barrier
|
GO:0061436 |
14 |
0.013
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.013
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
115 |
0.013
|
|
|
|
cellular response to cadmium ion
|
GO:0071276 |
3 |
0.013
|
|
|
|
mesonephric duct morphogenesis
|
GO:0072180 |
4 |
0.013
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.013
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.013
|
|
|
|
oligopeptide transmembrane transport
|
GO:0035672 |
4 |
0.013
|
|
|
|
muscle fiber development
|
GO:0048747 |
76 |
0.013
|
|
|
|
myelination
|
GO:0042552 |
74 |
0.013
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.013
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.013
|
|
|
|
intracellular mrna localization
|
GO:0008298 |
4 |
0.013
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.013
|
|
|
|
sodium ion transmembrane transport
|
GO:0035725 |
49 |
0.013
|
|
|
|
cochlea development
|
GO:0090102 |
35 |
0.013
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.013
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.013
|
|
|
|
spongiotrophoblast layer development
|
GO:0060712 |
15 |
0.013
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.013
|
|
|
|
leukocyte homeostasis
|
GO:0001776 |
79 |
0.013
|
|
|
|
phosphatidylethanolamine biosynthetic process
|
GO:0006646 |
2 |
0.013
|
|
|
|
response to vitamin a
|
GO:0033189 |
1 |
0.013
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.013
|
|
